The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding
- 1 February 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 25 (1) , 59-73
- https://doi.org/10.1097/01.jcp.0000150228.61501.e4
Abstract
Mood and anxiety disorders are common in women during their childbearing years. The prevalence of depression has been reported to be between 10% and 16% during pregnancy. The use of selective serotonin reuptake inhibitors during pregnancy or lactation is, to date, not promoted because of lack of safety documentation. However, the off-label use of these drugs has been common for several years. In the treatment of mood and anxiety disorders during pregnancy, the serotonin reuptake inhibitors are often preferred over tricyclic antidepressants because of their relatively few adverse effects and safety in overdose. This has created concern among women planning pregnancies and pregnant women, as well as among their families and physicians. Several studies and reports of the use of serotonin reuptake inhibitors during both pregnancy and lactation have been published and advanced our knowledge. We here review and discuss those studies which have been published so far on this subject.Keywords
This publication has 73 references indexed in Scilit:
- Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn NeurobehaviorPediatrics, 2004
- Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitorsActa Paediatrica, 2001
- Neonatal paroxetine withdrawal syndromeArchives of Disease in Childhood: Fetal & Neonatal, 2001
- Paroxetine in human milkBritish Journal of Clinical Pharmacology, 1999
- Excretion of citalopram in breast milkBritish Journal of Clinical Pharmacology, 1997
- Excretion of Fluoxetine and Its Metabolite, Norfluoxetine, in Human Breast MilkThe Journal of Clinical Pharmacology, 1996
- Effects of Third Trimester Fluoxetine Exposure on the NewbornJournal of Clinical Psychopharmacology, 1995
- Suspected congenital sertraline dependenceThe British Journal of Psychiatry, 1995
- PRENATAL STRESSORS OF HUMAN LIFE AFFECT FETAL BRAIN DEVELOPMENTDevelopmental Medicine and Child Neurology, 1994
- Developmental Toxicology Studies of Fluoxetine Hydrochloride Administered Orally to Rats and RabbitsFundamental and Applied Toxicology, 1994